Portfolio

Ambiq Micro (Fund I)

Ultra-low power MCUs for weables and IoT devices

AnnJI Pharma (Fund II)

Small molecule drugs for dermatology and neurology

AEye (Fund I)

Delivering human perception for autonomous vehicles

Arris Composites (Fund I)

Revolutionizing the manufacturing process of carbon fiber composites

Artilux (Fund I)

Pioneer in advanced GeSi photonic technology for wide spectrum 3D sensing and communication.

C4 Therapeutics (Fund II)

Destroying proteins that cause cancers, neurological, and other diseases.

DSP Concepts (Fund I)

The ultimate solution provider for audio DSP

EirGenix (Fund II)

Making biosimilars affordable and accessible to patients everywhere

ELIXIRON (Fund II)

Unique Immunotherapies for presently untreatable cancers and chronic hepatitis B

FRACTYL (Fund II)

Leveraging intestinal biology to transform the treatment of metabolic diseases

Frequency Therapeutics (Fund II)

Activating the body’s innate healing ability to treat degenerative diseases

Handa Pharma (Fund II)

Niche new drugs and high barrier/patentable products

LANDING AI (Fund I)

Helping companies jumpstart AI adoption and create real business value today

LIGHT FIELD LAB (Fund I)

Real holograms without the need of headgears

MedicusTeck (Fund I)

Predictive bed fall prevention and patient monitoring tool

Mechavision (Fund I)

Empowering human-machine collaboration through touch

Metanoia Communications Inc. (Fund I)

System on Chip (SoC) solutions for fixed line communication

OCULii (Fund I)

Breakthrough 4D radar imaging for autonomous systems

Pavilion Data Systems (Fund I)

High performance storage solution for enterprises

PharmaEssentia (Fund II)

Novel treatments for myeloproliferative neoplasms (MPNs), hepatitis, and cancers.

Point Robotics MedTec (Fund II)

Advanced robotics that makes spinal surgeries safer than ever

Regenacy Pharmaceuticals (Fund II)

Restoring nerve function to treat diabetic and other peripheral neuropathies

TRICORNTECH (Fund I)

Laboratory-grade VoC detectors for real time monitoring

Viracta (Fund II)

New medicines for cancers and virus-associated diseases

XGene (Fund II)

Small molecule drugs for acute pain, chronic pain and infectious diseases